Orthostatic Intolerance and Hypotension After Administration of Morphine in Patients Prior to Hip or Knee Arthroplasty
NCT ID: NCT04902222
Last Updated: 2021-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
26 participants
OBSERVATIONAL
2021-04-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties
NCT06832995
Ketamine Associated With Morphine PCA After Total Hip Arthroplasty
NCT00797264
Postoperative Analgesia After Total Hip Replacement
NCT00219921
PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
NCT02244619
Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy
NCT02530151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies have found a high incidence of postoperative OI (\> 40 %) among patients undergoing total hip arthroplasty.
A possible causative factor to the high occurrence of OH and OI after surgery could be postoperative pain management by administration of morphine. Morphine is known to have many side-effects including nausea, vomiting, dizziness and orthostatic hypotension.
The object of this study is to isolate and estimate the effect of intravenous morphine on the incidence of OH and OI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing primary hip or knee arthroplasty
Patients undergoing primary hip or knee arthroplasty
Morphine
Administration of 0.1 mg/kg (IBW) intravenous morphine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morphine
Administration of 0.1 mg/kg (IBW) intravenous morphine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients \> 18
* Patients that understand and speak Danish
* Patients that have provided written informed consent
Exclusion Criteria
* Habitual use of opioids
* Habitual use of anxiolytic, antidepressant and/or antipsychotic drugs
* History of previous orthostatic intolerance or hypotension
* Cognitive dysfunction
* Glomerular filtration rate (GFR) \< 30 ml/min
* Cardiac arrhythmia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kehlet, Henrik, M.D., Ph.D.
INDIV
Copenhagen University Hospital, Hvidovre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bodil Uldall-Hansen
Research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolai Bang Foss, Dr. Med.
Role: STUDY_DIRECTOR
Copenhagen University Hospital, Hvidovre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hvidovre University Hospital
Hvidovre, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20071567
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.